Cargando…
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Senescence is a tumor-suppressive mechanism induced by telomere shortening, oncogenes, or chemotherapy treatment. Although it is clear that this suppressive pathway leads to a permanent arrest in primary cells, this might not be the case in cancer cells that have inactivated their suppressive pathwa...
Autores principales: | Guillon, Jordan, Petit, Coralie, Moreau, Marie, Toutain, Bertrand, Henry, Cécile, Roché, Henry, Bonichon-Lamichhane, Nathalie, Salmon, Jean Paul, Lemonnier, Jérôme, Campone, Mario, Verrièle, Véronique, Lelièvre, Eric, Guette, Catherine, Coqueret, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393582/ https://www.ncbi.nlm.nih.gov/pubmed/30814491 http://dx.doi.org/10.1038/s41419-019-1406-7 |
Ejemplares similares
-
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
por: Le Duff, Mélanie, et al.
Publicado: (2018) -
tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR
por: Guillon, Jordan, et al.
Publicado: (2021) -
Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis
por: Vétillard, Alexandra, et al.
Publicado: (2015) -
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy-induced senescence escape
por: Maarouf, Amine, et al.
Publicado: (2021) -
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
por: Jonchère, Barbara, et al.
Publicado: (2014)